About
Mycophenolate sodium is an immunosuppressive agent primarily used in combination with other medications, such as cyclosporine and corticosteroids, to prevent organ rejection in patients receiving kidney, heart, or liver transplants. It acts as a selective, non-competitive, and reversible inhibitor of inosine monophosphate dehydrogenase (IMPDH), an enzyme crucial for the de novo synthesis of guanosine nucleotides. Lymphocytes, particularly B and T cells, are highly dependent on this pathway for proliferation, whereas other cell types can utilize salvage pathways. By inhibiting IMPDH, mycophenolate sodium effectively depletes guanosine nucleotides in lymphocytes, thereby suppressing their proliferation and differentiation, and ultimately inhibiting antibody formation and cell-mediated immune responses. This targeted action helps to prevent the immune system from attacking and rejecting the transplanted organ.
Uses
- Prevention of kidney transplant rejection.
- Prevention of heart transplant rejection.
- Prevention of liver transplant rejection.
- Used in combination with other immunosuppressants.
Directions For Use
Take this medication orally, usually twice daily, on an empty stomach, exactly as prescribed by your physician. Do not crush, chew, or cut the tablets.
Benefits
- Effective in preventing acute and chronic organ rejection.
- Reduces the incidence of graft loss.
- Improves long-term survival of transplanted organs.
- A key component of multi-drug immunosuppressive regimens.
- Helps maintain the function of the transplanted organ.
- Contributes to improved quality of life for transplant recipients.
Side Effects
- Diarrhea
- Nausea
- Vomiting
- Abdominal pain
- Leukopenia (low white blood cell count)
- Anemia
- Thrombocytopenia (low platelet count)
- Increased risk of infections
- Headache
- Hypertension
- Tremor
- Increased risk of certain malignancies
Safety Measures
- Alcohol - Alcohol consumption should be limited or avoided as it may increase the risk of gastrointestinal side effects and could potentially interact with the medication.
- Pregnancy - Mycophenolate sodium is highly teratogenic and can cause severe birth defects and miscarriage. It is contraindicated in pregnancy. Women of childbearing potential must use two reliable forms of contraception before, during, and for 6 weeks after treatment.
- Breastfeeding - Mycophenolate sodium is excreted into breast milk and can cause serious adverse reactions in a nursing infant. Breastfeeding is contraindicated.
- Liver - Use with caution in patients with severe liver impairment. Dose adjustments may be necessary, and liver function should be monitored.
- Kidney - Use with caution in patients with severe chronic kidney impairment. Dose adjustments may be required, and renal function should be closely monitored.
- Lung - Rarely, mycophenolate has been associated with pulmonary fibrosis or interstitial lung disease. Patients should report any new or worsening respiratory symptoms to their doctor.
Disclaimer
MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.
Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.
Our goal is to complement, not replace, the essential doctor-patient relationship.
| Shipping Cost |
|
| Shop Location | Assam, India |
No comments found for this product. Be the first to comment!